Control Bionics Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 2.96 million compared to AUD 2.9 million a year ago. Revenue was AUD 3.49 million compared to AUD 2.98 million a year ago.

Net loss was AUD 2.19 million compared to AUD 3 million a year ago. Basic loss per share from continuing operations was AUD 0.0206 compared to AUD 0.033 a year ago. Diluted loss per share from continuing operations was AUD 0.0206 compared to AUD 0.033 a year ago.